Monday, 22 March 2021

IDH receives FRA registration approval as a preliminary step for its dual listing and trading on the Egyptian Exchange

(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that it has received approval from the Egyptian Financial Regulatory Authority (“the FRA”) to proceed with a dual listing of the Company’s ordinary shares on the Egyptian Exchange (“the EGX”), which IDH believes will be complementary to its current listing on the London Stock Exchange (“the LSE”).

Tap or click here to read the announcement